# Richard G. Langley

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/richard-g-langley/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,270 |
| Field | Psoriasis: Treatment and Pathogenesis |
| h-index | 76 |
| i10-index | 187 |
| Last Known Institution | Dalhousie University |
| OpenAlex ID | https://openalex.org/A5061849637 |
| ORCID iD | https://orcid.org/0000-0003-4730-2164 |
| Works | 422 |

## Researcher papers

- [Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)](https://scholariq.org/papers/efficacy-and-safety-of-ustekinumab-a-human-interleukin-12-23-monoclonal-antibody-2/)
- [Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial](https://scholariq.org/papers/adalimumab-therapy-for-moderate-to-severe-psoriasis-a-randomized-controlled/)
- [Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis](https://scholariq.org/papers/phase-3-trials-of-ixekizumab-in-moderate-to-severe-plaque-psoriasis/)
- [Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis](https://scholariq.org/papers/phase-3-studies-comparing-brodalumab-with-ustekinumab-in-psoriasis/)
- [Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey](https://scholariq.org/papers/patient-perspectives-in-the-management-of-psoriasis-results-from-the-population/)
- [Bimekizumab versus Secukinumab in Plaque Psoriasis](https://scholariq.org/papers/bimekizumab-versus-secukinumab-in-plaque-psoriasis/)
- [Etanercept Treatment for Children and Adolescents with Plaque Psoriasis](https://scholariq.org/papers/etanercept-treatment-for-children-and-adolescents-with-plaque-psoriasis/)
- [Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents](https://scholariq.org/papers/safety-and-efficacy-of-pimecrolimus-asm-981-cream-1-in-the-treatment-of-mild-and/)

## Researcher topics

- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Spondyloarthritis Studies and Treatments](https://scholariq.org/topics/spondyloarthritis-studies-and-treatments/)
- [Pharmaceutical studies and practices](https://scholariq.org/topics/pharmaceutical-studies-and-practices/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

## Researcher university

- [Dalhousie University](https://scholariq.org/institutions/dalhousie-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.